Lava Therapeutics
LVTX
NZ$2.55
Share price
6.29%
Change (1 day)
-25.58%
Change (1 year)
Categories
P/S ratio for Lava Therapeutics (LVTX)
P/S ratio as of July 2025 (TTM): 8.01
According to Lava Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.55. At the end of 2025 the company had a P/S ratio of 6.80.
P/S ratio history for Lava Therapeutics from 2023 to 2021
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 6.80 | 211.81% |
| 2024 | 2.18 | -64.47% |
| 2023 | 6.14 | |
| 2021 | 24.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |